Ali A. Rizvi
About
Ali A. Rizvi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology.
According to data from OpenAlex, Ali A. Rizvi has authored 127 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Surgery and 25 papers in Molecular Biology. Recurrent topics in Ali A. Rizvi's work include Diabetes Treatment and Management (30 papers), Diabetes Management and Research (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers). Ali A. Rizvi is often cited by papers focused on Diabetes Treatment and Management (30 papers), Diabetes Management and Research (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers). Ali A. Rizvi collaborates with scholars based in United States, Italy and Romania. Ali A. Rizvi's co-authors include Manfredi Rizzo, Angelo Maria Patti, Giuseppe Montalto, Anca Pantea Stoian, Roberto Bolli, Dragana Nikolić, Gregg W. Stone, Donald E. Cutlip, Rosaria Vincenza Giglio and Dean J. Kereiakes and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.
In The Last Decade
Ali A. Rizvi
123 papers receiving 4.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ali A. Rizvi United States | 38 | 1.7k | 1.4k | 1.2k | 887 | 668 | 127 | 4.5k | ||
| Jian‐Jun Li China | 37 | 1.9k 1.1× | 1.1k 0.8× | 1.9k 1.5× | 753 0.8× | 368 0.6× | 259 | 5.7k | ||
| Gemma Vilahur Spain | 45 | 1.8k 1.1× | 682 0.5× | 2.6k 2.1× | 1.9k 2.1× | 546 0.8× | 206 | 7.2k | ||
| Elmo Mannarino Italy | 50 | 1.6k 1.0× | 1.2k 0.9× | 2.9k 2.3× | 1.0k 1.2× | 537 0.8× | 206 | 7.6k | ||
| Koji Oba Japan | 37 | 1.4k 0.8× | 725 0.5× | 633 0.5× | 930 1.0× | 473 0.7× | 273 | 5.7k | ||
| Manuel Castro Cabezas Netherlands | 37 | 999 0.6× | 1.6k 1.2× | 1.2k 0.9× | 732 0.8× | 217 0.3× | 150 | 5.1k | ||
| Seok‐Min Kang South Korea | 43 | 1.2k 0.7× | 733 0.5× | 3.7k 3.0× | 1.1k 1.2× | 231 0.3× | 425 | 7.0k | ||
| Hung‐Chun Chen Taiwan | 40 | 806 0.5× | 670 0.5× | 1.1k 0.9× | 742 0.8× | 372 0.6× | 260 | 5.4k | ||
| Dario Pitocco Italy | 40 | 1.3k 0.7× | 2.2k 1.5× | 990 0.8× | 983 1.1× | 352 0.5× | 203 | 5.7k | ||
| Andreas J. Flammer Switzerland | 36 | 941 0.5× | 549 0.4× | 2.3k 1.9× | 849 1.0× | 244 0.4× | 136 | 6.1k | ||
| Lorraine C. Racusen United States | 58 | 2.6k 1.5× | 480 0.3× | 438 0.4× | 1.7k 1.9× | 555 0.8× | 160 | 9.5k |
Countries citing papers authored by Ali A. Rizvi
Since
Specialization
Citations
This map shows the geographic impact of Ali A. Rizvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali A. Rizvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali A. Rizvi more than expected).
Fields of papers citing papers by Ali A. Rizvi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ali A. Rizvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali A. Rizvi. The network helps show where Ali A. Rizvi may publish in the future.
Co-authorship network of co-authors of Ali A. Rizvi
This figure shows the co-authorship network connecting the top 25 collaborators of Ali A. Rizvi. A scholar is included among the top collaborators of Ali A. Rizvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali A. Rizvi. Ali A. Rizvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Patti, Angelo Maria, Rosaria Vincenza Giglio, Marcello Ciaccio, et al.. (2025). New Frontiers in Nutritional and Therapeutic Interventions for Obesity Phenotypes. Medicina. 61(4). 664–664.
2.
Admane, Sonal, Patricia Bramati, Bryan Fellman, et al.. (2025). Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021. JCO Oncology Practice. 21(11). 1656–1664.
3.
Banerjee, Yajnavalka, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.. (2023). The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance. Journal of Diabetes and its Complications. 37(8). 108517–108517.
4.
Salmen, Teodor, Cristian Serafinceanu, Emir Muzurović, et al.. (2023). A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy—A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 24(11). 9760–9760.
5.
Giglio, Rosaria Vincenza, Angelo Maria Patti, Ali A. Rizvi, et al.. (2023). Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update. Biomedicines. 11(2). 291–291.
6.
Salmen, Teodor, Ali A. Rizvi, Manfredi Rizzo, et al.. (2023). Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus—A Real-Life Clinical Practice Study. Biomedicines. 11(9). 2455–2455.
7.
Reddy, Akhila, Ali A. Rizvi, Nico Nortjé, et al.. (2023). Impact of an Institution-Wide Goals of Care Program on the Timing of Referrals to Outpatient Palliative Care. Journal of Pain and Symptom Management. 66(6). e666–e671.
8.
Giglio, Rosaria Vincenza, Νικόλαος Παπάνας, Ali A. Rizvi, et al.. (2022). An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes. Medicina. 58(10). 1475–1475.
9.
Dascălu, Ana Maria, Manfredi Rizzo, Ali A. Rizvi, et al.. (2022). Safety and Outcomes of Intravitreal Aflibercept in Diabetic Macular Edema – ASystematic Review. Current Pharmaceutical Design. 28(21). 1758–1768.
10.
Popoviciu, Mihaela Simona, Cosmin Mihai Vesa, Roxana Adriana Stoica, et al.. (2022). Correlations between Diabetes Mellitus Self-Care Activities and Glycaemic Control in the Adult Population: A Cross-Sectional Study. Healthcare. 10(1). 174–174.
11.
Patti, Angelo Maria, Rosaria Vincenza Giglio, Νικόλαος Παπάνας, et al.. (2022). Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes. Medicina. 58(1). 109–109.
12.
Arner, Emily N., Ali A. Rizvi, Jason E. Toombs, et al.. (2021). AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer. Molecular Cancer Therapeutics. 21(1). 38–47.
13.
Şerban, Dragoş, Νικόλαος Παπάνας, Ana Maria Dascălu, et al.. (2021). Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets. The International Journal of Lower Extremity Wounds. 23(2). 205–216.
14.
Giglio, Rosaria Vincenza, Anca Pantea Stoian, Khalid Al‐Rasadi, et al.. (2021). Novel Therapeutical Approaches to Managing Atherosclerotic Risk. International Journal of Molecular Sciences. 22(9). 4633–4633.
15.
Giglio, Rosaria Vincenza, Anca Pantea Stoian, Angelo Maria Patti, et al.. (2021). Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome. Current Pharmaceutical Design. 27(35). 3729–3740.
16.
Rizvi, Ali A., Anca Pantea Stoian, Andrej Janež, & Manfredi Rizzo. (2021). Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options. Biomedicines. 9(11). 1579–1579.
17.
Patti, Angelo Maria, Ali A. Rizvi, Rosaria Vincenza Giglio, et al.. (2020). Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes. Journal of Clinical Medicine. 9(4). 912–912.
18.
Giglio, Rosaria Vincenza, Giuseppe Carruba, Arrigo F.G. Cicero, et al.. (2020). Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study. Metabolites. 10(11). 428–428.
19.
Patti, Angelo Maria, Giuseppe Carruba, Arrigo F.G. Cicero, et al.. (2020). Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study. Metabolites. 10(10). 392–392.
20.
Giglio, Rosaria Vincenza, Dragana Nikolić, Giovanni Li Volti, et al.. (2020). Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect. Metabolites. 10(10). 391–391.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jian‐Jun Li Breakdown of academic impact, for papers by Gemma Vilahur Breakdown of academic impact, for papers by Elmo Mannarino Breakdown of academic impact, for papers by Koji Oba Breakdown of academic impact, for papers by Manuel Castro Cabezas Breakdown of academic impact, for papers by Seok‐Min Kang Breakdown of academic impact, for papers by Hung‐Chun Chen Breakdown of academic impact, for papers by Dario Pitocco Breakdown of academic impact, for papers by Andreas J. Flammer Breakdown of academic impact, for papers by Lorraine C. Racusen